News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)Next EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News Trident Drives Engagement for Singapore’s National Day Parade 2025 News Cloudera Data Services Brings Private AI to the Data Center News Bank Negara Indonesia Strengthens Partnership with Cloudera to Scale AI-Powered Business Transformation News Epiq AI Labs™ Announces New Corporate, Law Firm, and Academic Members News HKTDC appoints Sophia CHONG as Executive Director News Imagen Network Builds Adaptive Content Filters Using Grok to Boost Engagement Quality
